Ofatumumab Bendamustine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ofatumumab Bendamustine, covering 2020-03-27 to 2020-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy [Phase 3]